Micropatterning Polymer Materials to Improve Endothelialization

Abstract:

Several studies have shown that 65 % of expanded poly (tetrafluoroethylene) (ePTFE) vascular prostheses had to be explanted within 10 years of implantation in humans. The reasons for these explantations relied on thrombosis formation and poor hemocompatibility of synthetic polymers. It has been shown that surface modification of ePTFE arterial prostheses could enable their endothelialization therefore improving their biocompatibility and hemocompatibility. Indeed, endothelial cells naturally cover the biological blood vessel wall and consequently, an endothelial layer constitutes the best achievable hemocompatible surface. In this context, our strategy consisted in micropatterning cell adhesion (RGD) and proliferation (WQPPRARI) peptides on the surface of plasma-functionalized PTFE, therefore enabling covalent conjugation of the peptides. Basically, the technology consisted in spraying a solution of the adhesion peptide, therefore leading to 10 µm-diameter RGD spots semi-randomly distributed over the sample and covering 20 % of the whole polymer surface. In a second step, proliferation peptide was applied to the remaining surface by soaking, therefore covering the unreacted surface. The 20 % coverage was obtained by using an x-y table, programmed to move from side to side of the surface on x value, with an increment on y value that has been calibrated.

• Periodical: Advanced Materials Research (Volume 409)
• Pages: 777-782
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.409.777
• Online since: November 2011
• Authors: Marie Claude Boivin, P. Chevallier, Stéphane Turgeon, Jean Lagueux, Gaetan Laroche
• Keywords: Micropatterning, Peptide, Surface Modification

References

[1] M.C. Porte-Durrieu, C. Labrugere, F. Villars, F. Lefebvre, S. Dutoya, A. Guette, L. Bordenave and C. Baquey: J. Biomed. Mater. Res. Vol. 46 (1999), pp.368-375.

DOI: 10.1002/(sici)1097-4636(19990905)46:3<368::aid-jbm9>3.0.co;2-8

[2] S.P. Massia and J.A. Hubbell: J. Biomed. Mater. Res. Vol. 25 (1991), pp.223-242.

[3] A. Tiwari, A. Kidane, H. Salacinski, G. Punshon, G. Hamilton and A.M. Seifalan: Eur. J. Vasc. Endovasc. Surg. Vol. 25 (2003), pp.325-329.

[4] K.P. Walluscheck, G. Steinhoff, S. Kelm and A. Haverich: Eur. J. Vasc. Endovasc. Surg. Vol. 12 (1996), pp.321-330.

[5] S.P. Massia and J. Stark: J. Biomed. Mater. Res. Vol. 56 (2001), pp.390-399.

[6] G.M. Whitesides, E. Ostuni, S. Takayama, X. Jiang and D.E. Ingber: Ann. Rev. Biomed. Eng. Vol. 3 (2001), pp.335-373.

[7] C.S. Chen, M. Mrksich, S. Huang, G.M. Whitesides and D.E. Ingber: Biotechnol. Prog. Vol. 14 (1998), pp.356-363.

DOI: 10.1021/bp980031m

[8] N.D. Gallant, J.R. Capadona, A.B. Frazier, D.M. Collard and A.J. Garcia: Langmuir Vol. 18 (2002), pp.5579-5584.

[9] T.G. Vargo, P.M. Thompson, L.J. Gerenser, R.F. Valentini, P. Aebischer, D.J. Hook and J.A. Gardella, Jr.: Langmuir Vol. 8 (1992), pp.130-134.

DOI: 10.1021/la00037a025

[10] V. Gauvreau and G. Laroche: Bioconjug Chem Vol. 16 (2005), pp.1088-97.

[11] L. Gagne, G. Rivera and G. Laroche: Biomaterials Vol. 27 (2006), pp.5430-9.

[12] C. Sarra-Bournet, G. Ayotte, S. Turgeon, F. Massines and G. Laroche: Langmuir Vol. 25 (2009), pp.9432-40.

DOI: 10.1021/la900652y

[13] V. Gauvreau, P. Chevallier, K. Vallieres, E. Petitclerc, R.C. Gaudreault and G. Laroche: Bioconjug Chem Vol. 15 (2004), pp.1146-56.

[14] K. Vallieres, E. Petitclerc and G. Laroche: Macromol Biosci Vol. 7 (2007), pp.738-45.

[15] L.A.L. Gagne, G.: Advanced Materials Research Vol. 15-17 (2007), pp.77-82.

[16] W.S. Rasband, ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, http: /rsb. info. nih. gov/ij/, 1997-(2009).